<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03246256</url>
  </required_header>
  <id_info>
    <org_study_id>EA4/140/16</org_study_id>
    <nct_id>NCT03246256</nct_id>
  </id_info>
  <brief_title>Information Recall on Informed Consent to Intravenous Thrombolysis in Patients With Acute Ischaemic Stroke.</brief_title>
  <official_title>Recall of Information on Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Given During Informed Consent: a Prospective Observational Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Neurology, Charité - Universitätsmedizin Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Cardiology and Pneumology, Charité, Campus Benjamin Franklin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the ability to recall information given during
      informed consent on intravenous thrombolysis in patients with acute ischaemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective multi-center study is to investigate whether patients with
      acute ischaemic stroke are able to recall information given before providing informed consent
      to intravenous thrombolysis after the end of treatment. Patients with acute ischaemic stroke
      will be compared to a group of relatives who witnessed the informed consent procedure of a
      relative with acute ischaemic stroke, stroke patients who were not treated with intravenous
      thrombolysis and patients without an ischaemic stroke but similiar risk factors (admitted to
      the Departement of Cardiology and Pneumology, Charité, Campus Benjamin Franklin, Berlin,
      Germany).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recall of the designated facts given during informed consent procedure on intravenous thrombolysis after acute ischaemic stroke</measure>
    <time_frame>Within 24 hours</time_frame>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients with acute ischaemic stroke who were administered intavenous thrombolysis or patients with acute ischaemic stroke refusing intravenous thrombolysis; recall in both cases 60 to 90 minutes after the informed consent procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>1st of 2nd degree relatives of patients with acute ischaemic stroke, who witnessed the informed consent procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Stroke patients with acute or subacute ischaemic stroke with a contraindication for intravenous thrombolysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>Patients without an ischaemic stroke but similiar risk factors (admitted to the Departement of Cardiology and Pneumology, Charité, Campus Benjamin Franklin, Berlin, Germany)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <description>Patients with acute ischaemic stroke who were administered intavenous thrombolysis - recall 24 hours after the informed consent procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group 1</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <other_name>Group 2</other_name>
    <other_name>Group 3</other_name>
    <other_name>Group 4</other_name>
    <other_name>Group 5</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischaemic stroke and intravenous thrombolysis or patients with acute
        ischaemic stroke refusing intravenous thrombolysis, relatives (1st or 2nd degree) of
        patients with acute ischaemic stroke, patient with acute or subacute ischaemic stroke with
        a contraindication for intravenous thrombolysis and patients without acute ischaemic stroke
        (admitted to the Department of Cardiology (Charité, Campus Benjamin Franklin, Germany).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria (all):

          -  age ≥18 years

          -  able to give informed consent

          -  ability to understand and read German

          -  no prior i.v.-thrombolysis

        Additional inclusion criteria - patients with acute ischaemic stroke:

          -  suspected ischaemic stroke (according to brain CT) or MRI-proven acute ischaemic
             stroke

          -  indication for intravenous thrombolysis

        Additional inclusion criteria - relatives:

        · relative (1st or 2nd dregree) of a patient with acute ischaemic stroke and present during
        the informed consent procedure

        Additional inclusion criteria - stroke patients with a contraindication for thrombolysis:

          -  ischaemic stroke (according to brain MRI or CT)

          -  contraindication for intravenous thrombolysis

        Additional inclusion criteria - non-stroke patients:

        · present admission at the Department of Cardiology and Pneumology, Charité -
        Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

        Exclusion criteria (all groups):

          -  not able to give imformed consent or under legal supervision/guardianship

          -  participation in an interventional study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karl Georg Häusler, MD</last_name>
    <phone>+49 30 450 560 676</phone>
    <email>georg.haeusler@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luzie K Koehler, MD</last_name>
    <phone>+49 30 450 560 698</phone>
    <email>luzie.koehler@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Georg Häusler, MD</last_name>
      <phone>+49 30 450 560 676</phone>
      <email>georg.haeusler@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Luzie K. Koehler, MD</last_name>
      <phone>+49 30 450 560 698</phone>
      <email>luzie.koehler@charite.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waltraud Pfeilschifter, MD</last_name>
      <email>waltraud.pfeilschifter@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timolaos Rizos, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Stadt Ludwigshafen a. Rh.</name>
      <address>
        <city>Ludwigshafen am Rhein</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederick Palm, MD</last_name>
      <email>PALMF@klilu.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Karl Georg Haeusler</investigator_full_name>
    <investigator_title>Consultant Neurologist</investigator_title>
  </responsible_party>
  <keyword>acute</keyword>
  <keyword>informed consent</keyword>
  <keyword>thrombolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

